Home » Topics » Disease categories and therapies » Urology

Urology
RSS

(+)-SNAP-6991 discovered at Synaptic and Merck as orally active, uroselective alpha1a blocker

April 5, 1999

New antimuscarinic piperidine derivative from Taisho inhibits bladder contractions

April 1, 1999

Pharmacokinetics and pharmacodynamics of VPA-985 in healthy volunteers

March 31, 1999

Aminoethylphenoxyacetic acids for urinary lithiasis in development at Kissei

March 30, 1999

U.S. patent issues to Vivus for second-generation ED therapeutic

March 29, 1999

Asahi Chemical launches alpha-adrenoceptor antagonist in Japan

March 26, 1999

Potassium and/or chloride channel modulators claimed for incontinence and IBS

March 25, 1999

Dainippon's AH-9700 is an excellent candidate for treatment of urge incontinence

March 25, 1999

Recordati presents new series for lower urinary tract dysfunction

March 24, 1999

American Home Products patents selective, orally active, nonpeptide V2 agonists

March 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...